Ameritas Investment Company’s iShares Biotechnology ETF IBB Stock Holding History

Ameritas Investment Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.42M	Buy	8,790 +3,765	+75%	+$634K	0.07%	230
2021 Q2	$1.46M	Sell	5,025 -1,215	-19%	-$187K	0.07%	232
2021 Q1	$939K	Buy	6,240 +741	+13%	+$118K	0.08%	232
2020 Q4	$833K	Buy	5,499 +1,166	+27%	+$167K	0.16%	143
2020 Q3	$592K	Hold	4,333	–	–	0.19%	146
2020 Q2	$592K	Sell	4,333 -3,087	-42%	-$394K	0.17%	150
2020 Q1	$795K	Buy	7,420 +3,114	+72%	+$359K	0.13%	137
2019 Q4	$519K	Sell	4,306 -3,096	-42%	-$345K	0.11%	181
2019 Q3	$766K	Buy	7,402 +3,031	+69%	+$317K	0.15%	126
2019 Q2	$477K	Sell	4,371 -4,522	-51%	-$481K	0.23%	104
2019 Q1	$995K	Buy	+8,893	New	+$975K	0.18%	104

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Ameritas Investment Company's IBB Position: Q3 2021 in Review

Ameritas Investment Company increased its iShares Biotechnology ETF (IBB) stake by 75% in Q3 2021, buying an estimated $634K and bringing the position to 8,790 shares worth $1.42M. The position accounts for 0.07% of the portfolio, ranked #230.

Ameritas Investment Company first reported a position in IBB in Q1 2019 and has held it in 11 quarters since. The position peaked at $1.46M in Q2 2021. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

Ameritas Investment Company held 8,790 shares of iShares Biotechnology ETF worth $1.42M as of Q3 2021.
Ameritas Investment Company bought 3,765 iShares Biotechnology ETF shares in Q3 2021, an estimated $634K.
iShares Biotechnology ETF made up 0.07% of Ameritas Investment Company's portfolio in Q3 2021, its #230 holding.
Ameritas Investment Company first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 11 quarters since.
Ameritas Investment Company's iShares Biotechnology ETF position peaked at $1.46M in Q2 2021.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.